Cleared Traditional

AssureTech Panel Dip Tests (K243996) - FDA 510(k) Clearance

Also marketed or referenced as:
AssureTech Quick Cup Tests AssureTech Multi-drug Urine Test Panel AssureTech Multi-drug Urine Test Cup

Class II Toxicology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
43d
Days
Class 2
Risk

K243996 is an FDA 510(k) clearance for the AssureTech Panel Dip Tests. Classified as Test, Amphetamine, Over The Counter (product code NFT), Class II - Special Controls.

Submitted by Assure Tech., LLC (Wilmington, US). The FDA issued a Cleared decision on February 7, 2025 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3100 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Assure Tech., LLC devices

Submission Details

510(k) Number K243996 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2024
Decision Date February 07, 2025
Days to Decision 43 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 87d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFT Test, Amphetamine, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Consultant

LSI International, Inc.
Jenny Xia

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFT Test, Amphetamine, Over The Counter

All 28
Devices cleared under the same product code (NFT) and FDA review panel - the closest regulatory comparables to K243996.
AssureTech Quick Cup Tests
K252259 · Assure Tech., LLC · Aug 2025
AllTest Multi-Drug Rapid Urine Test Cup
K250727 · Hangzhou AllTest Biotech Co., Ltd. · Apr 2025
AllTest Multi-Drug Rapid Test Cup
K244043 · Hangzhou AllTest Biotech Co., Ltd. · Feb 2025
Pocguide Multi-Drug Test Panel, Pocguide Multi-Drug Test Panel OTC
K242498 · Aicheck Biotech, Inc. · Oct 2024
AllTest Multi-Drug Urine Test Panel
K242540 · Hangzhou AllTest Biotech Co., Ltd. · Sep 2024
PocguideTM Multi-Drug Test Cup OTC, PocguideTM Multi-Drug Test Cup
K242077 · Aicheck Biotech, Inc. · Aug 2024